RESEARCHER PROFILE

Martin Löwer

← Back to Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz

M

Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesGlioma Diagnosis and Treatmentvaccines and immunoinformatics approachesCancer Genomics and Diagnostics

Martin Löwer works in Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Glioma Diagnosis and Treatment, vaccines and immunoinformatics approaches, Cancer Genomics and Diagnostics. Recorded institutional associations include University Medical Center of the Johannes Gutenberg University Mainz, Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz.

103Publications
9,913Citations
31H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

    2017 · 2,473 citations
  2. Mutant MHC class II epitopes drive therapeutic immune responses to cancer

    2015 · 1,237 citations
  3. Actively personalized vaccination trial for newly diagnosed glioblastoma

    2018 · 935 citations
  4. Exploiting the Mutanome for Tumor Vaccination

    2012 · 810 citations
  5. Identification of neoantigens for individualized therapeutic cancer vaccines

    2022 · 534 citations
  6. Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

    2020 · 531 citations
  7. Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening

    2018 · 362 citations
  8. Myeloid Cell-Derived Reactive Oxygen Species Induce Epithelial Mutagenesis

    2017 · 359 citations
  9. Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution

    2017 · 297 citations
  10. Helicobacter pylori HtrA is a new secreted virulence factor that cleaves E‐cadherin to disrupt intercellular adhesion

    2010 · 295 citations
  11. HLA typing from RNA-Seq sequence reads

    2012 · 270 citations
  12. Response definition criteria for ELISPOT assays revisited

    2010 · 225 citations
  13. Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model

    2020 · 210 citations
  14. Prediction of Type III Secretion Signals in Genomes of Gram-Negative Bacteria

    2009 · 118 citations
  15. Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial

    2025 · 118 citations
  16. Digital Genome-Wide ncRNA Expression, Including SnoRNAs, across 11 Human Tissues Using PolyA-Neutral Amplification

    2010 · 117 citations
  17. HLA and proteasome expression body map

    2018 · 105 citations
  18. A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines

    2014 · 102 citations
  19. Prediction of Extracellular Proteases of the Human Pathogen Helicobacter pylori Reveals Proteolytic Activity of the Hp1018/19 Protein HtrA

    2008 · 84 citations
  20. Bioinformatics for Cancer Immunotherapy

    2020 · 65 citations
  21. Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens

    2022 · 59 citations
  22. Inhibitors of Helicobacter pylori Protease HtrA Found by ‘Virtual Ligand’ Screening Combat Bacterial Invasion of Epithelia

    2011 · 55 citations
  23. Adhesion, Invasion, and Agglutination Mediated by Two Trimeric Autotransporters in the Human Uropathogen Proteus mirabilis

    2010 · 52 citations
  24. Challenges towards the realization of individualized cancer vaccines

    2018 · 47 citations
  25. Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination

    2015 · 42 citations

← Return to the university profile